| scholarly article | Q13442814 |
| P2093 | author name string | Tsuguhito Ota | |
| Henry N Ginsberg | |||
| Constance Gayet | |||
| P2860 | cites work | XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor | Q24292102 |
| Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78 | Q24306877 | ||
| Inflammation, stress, and diabetes | Q24523336 | ||
| A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death | Q24540224 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA | Q28214814 | ||
| Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase | Q28296183 | ||
| Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways | Q28365886 | ||
| Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload | Q28506232 | ||
| Regulated translation initiation controls stress-induced gene expression in mammalian cells | Q28506388 | ||
| Mechanisms of glucosamine-induced suppression of the hepatic assembly and secretion of apolipoprotein B-100-containing lipoproteins | Q28573980 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis | Q28576685 | ||
| Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B | Q28625242 | ||
| Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes | Q29615503 | ||
| Apolipoprotein B in the rough endoplasmic reticulum: translation, translocation and the initiation of lipoprotein assembly | Q33537983 | ||
| Tripartite management of unfolded proteins in the endoplasmic reticulum | Q33941135 | ||
| Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association | Q34112671 | ||
| Microsomal triglyceride transfer protein binding and lipid transfer activities are independent of each other, but both are required for secretion of apolipoprotein B lipoproteins from liver cells | Q73894187 | ||
| Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells | Q73965905 | ||
| Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis | Q81441036 | ||
| Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis | Q82677113 | ||
| Therapeutic approaches to protein-misfolding diseases | Q34285075 | ||
| Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins | Q34634838 | ||
| The unfolded protein response in nutrient sensing and differentiation | Q34664763 | ||
| Transcriptional and translational control in the Mammalian unfolded protein response | Q34762452 | ||
| Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion | Q35011167 | ||
| Regulation of plasma triglycerides in insulin resistance and diabetes | Q36144459 | ||
| Review: The role of insulin resistance in nonalcoholic fatty liver disease | Q36591903 | ||
| Endoplasmic reticulum stress signaling in disease | Q36610455 | ||
| Fatty liver and the metabolic syndrome | Q36724600 | ||
| Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency | Q37118167 | ||
| In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. | Q37374706 | ||
| Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production | Q37698834 | ||
| Factors affecting lipoprotein metabolism | Q40038704 | ||
| Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis | Q40294776 | ||
| Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells | Q40313352 | ||
| ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity | Q40386955 | ||
| The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. | Q40453939 | ||
| Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation. | Q40477226 | ||
| Increasing prevalence of the metabolic syndrome among u.s. Adults. | Q40479545 | ||
| Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy | Q40775950 | ||
| Inhibition of translocation of nascent apolipoprotein B across the endoplasmic reticulum membrane is associated with selective inhibition of the synthesis of apolipoprotein B. | Q40875126 | ||
| Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane | Q41161594 | ||
| Intracellular degradation of newly synthesized apolipoprotein B. | Q41646693 | ||
| Transient arrest in proteasomal degradation during inhibition of translation in the unfolded protein response | Q42088013 | ||
| The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways | Q43564087 | ||
| Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance | Q43764702 | ||
| Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease | Q44316104 | ||
| Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. | Q44317091 | ||
| Modulation of the JNK pathway in liver affects insulin resistance status | Q45032503 | ||
| Involvement of endoplasmic reticulum stress in insulin resistance and diabetes | Q45127777 | ||
| Intracellular assembly of VLDL: two major steps in separate cell compartments | Q45345943 | ||
| Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis | Q46695184 | ||
| Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 | ||
| Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals | Q47392377 | ||
| Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. | Q51031951 | ||
| The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions | Q52756540 | ||
| Liver pathology and the metabolic syndrome X in severe obesity. | Q54096450 | ||
| Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. | Q54191086 | ||
| Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein | Q56971926 | ||
| The degradation of apolipoprotein B100 is mediated by the ubiquitin-proteasome pathway and involves heat shock protein 70 | Q56971940 | ||
| Effects of fatty acids on apolipoprotein B secretion by McArdle RH-7777 rat hepatoma cells | Q60641840 | ||
| Techniques for the chronic cannulation of the jugular vein in mice | Q66948837 | ||
| Homocystinuria due to cystathionine synthase deficiency: enzymatic and ultrastructural studies | Q69735284 | ||
| VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin | Q72005778 | ||
| Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells | Q72571322 | ||
| Immunoglobulin binding protein (BiP) function is required to protect cells from endoplasmic reticulum stress but is not required for the secretion of selective proteins | Q73039105 | ||
| Lipid metabolism | Q73165028 | ||
| Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM | Q73250750 | ||
| Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed ham | Q73561026 | ||
| Metabolic basis of hypotriglyceridemic effects of insulin in normal men | Q73596778 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| P304 | page(s) | 316-332 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents | |
| P478 | volume | 118 |
| Q39035105 | 4-Phenylbutyrate inhibits tunicamycin-induced acute kidney injury via CHOP/GADD153 repression |
| Q83229108 | A critical role of VMP1 in lipoprotein secretion |
| Q38616263 | A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels |
| Q58697388 | A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis |
| Q52723007 | A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice. |
| Q42824021 | A protective role for CD154 in hepatic steatosis in mice |
| Q37132127 | ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice. |
| Q41764630 | Activating transcription factor 6 plays protective and pathological roles in steatosis due to endoplasmic reticulum stress in zebrafish |
| Q35913725 | Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice. |
| Q37635136 | Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences |
| Q38034114 | Allostasis in nonalcoholic fatty liver disease: implications for risk assessment |
| Q37408615 | Apolipoprotein B secretion is regulated by hepatic triglyceride, and not insulin, in a model of increased hepatic insulin signaling |
| Q28244602 | Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance |
| Q33858526 | Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion. |
| Q36316952 | Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E. |
| Q49687928 | Autophagy Dysregulation and Obesity-Associated Pathologies. |
| Q38336391 | Autophagy regulates insulin resistance following endoplasmic reticulum stress in diabetes |
| Q37000389 | Bax Inhibitor-1 regulates hepatic lipid accumulation via ApoB secretion |
| Q37728794 | Berberine reduces endoplasmic reticulum stress and improves insulin signal transduction in Hep G2 cells |
| Q33750735 | C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis |
| Q36047622 | CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status |
| Q51028250 | CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia. |
| Q47273262 | Cathepsin B Regulates Hepatic Lipid Metabolism by Cleaving Liver Fatty Acid Binding Protein |
| Q37863134 | Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? |
| Q33771982 | Circadian clock-coordinated hepatic lipid metabolism: only transcriptional regulation? |
| Q51188275 | Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress. |
| Q37485124 | Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis |
| Q37093059 | Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans |
| Q92255067 | Coupling of COPII vesicle trafficking to nutrient availability by the IRE1α-XBP1s axis |
| Q34200914 | Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease |
| Q49810183 | Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats |
| Q35152201 | Different fatty acids inhibit apoB100 secretion by different pathways: unique roles for ER stress, ceramide, and autophagy |
| Q33993213 | Distinct gene expression profiles characterize cellular responses to palmitate and oleate. |
| Q28073180 | Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training |
| Q50968208 | ER Stress Inhibits Liver Fatty Acid Oxidation while Unmitigated Stress Leads to Anorexia-Induced Lipolysis and Both Liver and Kidney Steatosis. |
| Q42199386 | ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development |
| Q36846138 | Effect of pioglitazone treatment on endoplasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines. |
| Q53825300 | Effect of the unfolded protein response on ER protein export: a potential new mechanism to relieve ER stress. |
| Q41985780 | Effect of α-linolenic acid on endoplasmic reticulum stress-mediated apoptosis of palmitic acid lipotoxicity in primary rat hepatocytes |
| Q36634922 | Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases |
| Q37784942 | Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes |
| Q64057135 | Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis |
| Q36904643 | Endoplasmic reticulum is at the crossroads of autophagy, inflammation, and apoptosis signaling pathways and participates in the pathogenesis of diabetes mellitus |
| Q38925531 | Endoplasmic reticulum proteostasis in hepatic steatosis. |
| Q38557011 | Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease |
| Q28279152 | Endoplasmic reticulum stress and atherosclerosis |
| Q35614922 | Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential |
| Q97522970 | Endoplasmic reticulum stress and liver diseases |
| Q24633352 | Endoplasmic reticulum stress and the inflammatory basis of metabolic disease |
| Q35055531 | Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease |
| Q38030876 | Endoplasmic reticulum stress in cardiometabolic disorders |
| Q38923148 | Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view |
| Q45200756 | Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor |
| Q44826419 | Endoplasmic reticulum stress: from physiology to pathogenesis of type 2 diabetes |
| Q35069547 | Eucommia ulmoides Oliver extract, aucubin, and geniposide enhance lysosomal activity to regulate ER stress and hepatic lipid accumulation |
| Q35601541 | Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease |
| Q34571695 | Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity |
| Q40021459 | Fatty acid-mediated endoplasmic reticulum stress in vivo: differential response to the infusion of Soybean and Lard Oil in rats |
| Q53654532 | Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. |
| Q37805344 | FoxO1 and hepatic lipid metabolism |
| Q37148966 | FoxO1 integrates insulin signaling to VLDL production |
| Q34132566 | FoxO1 links hepatic insulin action to endoplasmic reticulum stress |
| Q28507512 | FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice |
| Q37648011 | FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver. |
| Q37596560 | From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis |
| Q34800989 | From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations |
| Q36862673 | Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure |
| Q37170811 | GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice |
| Q43073146 | Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling |
| Q37892758 | Gut-liver interaction in triglyceride-rich lipoprotein metabolism |
| Q35809069 | Hepatic Steatosis as a Marker of Metabolic Dysfunction. |
| Q42484587 | Hepatic autophagy mediates endoplasmic reticulum stress-induced degradation of misfolded apolipoprotein B. |
| Q37777696 | Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites |
| Q34790153 | Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis. |
| Q33388523 | Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition |
| Q36395865 | Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases |
| Q28115216 | Hepatoprotective role of Sestrin2 against chronic ER stress |
| Q28606588 | High dietary cholesterol and ovariectomy in rats repress gene expression of key markers of VLDL and bile acid metabolism in liver |
| Q41788624 | Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone-induced liver damage through inflammation and endoplasmic reticulum stress. |
| Q36951181 | ILDR2: an endoplasmic reticulum resident molecule mediating hepatic lipid homeostasis |
| Q36600595 | IRE1α-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis |
| Q35077000 | Identification of protein disulfide isomerase 1 as a key isomerase for disulfide bond formation in apolipoprotein B100. |
| Q35776630 | Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion |
| Q35186665 | Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. |
| Q26752511 | Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1 |
| Q28236897 | Inflammation and cellular stress: a mechanistic link between immune-mediated and metabolically driven pathologies |
| Q83810163 | Infusion of glucose and lipids at physiological rates causes acute endoplasmic reticulum stress in rat liver |
| Q37395697 | Inhibition of apolipoprotein B synthesis stimulates endoplasmic reticulum autophagy that prevents steatosis |
| Q50280266 | Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo. |
| Q34238637 | Inhibition of the central melanocortin system decreases brown adipose tissue activity |
| Q38267212 | Insights from human congenital disorders of intestinal lipid metabolism |
| Q38974337 | Insulin injection restored increased insulin receptor substrate (IRS)-2 protein during short-term protein restriction but did not affect reduced insulin-like growth factor (IGF)-I mRNA or increased triglyceride accumulation in the liver of rats. |
| Q39150236 | Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases |
| Q34985745 | Intersection of the unfolded protein response and hepatic lipid metabolism |
| Q37897618 | Is fat so bad? Modulation of endoplasmic reticulum stress by lipid droplet formation |
| Q54349322 | Ixeris dentata decreases ER stress and hepatic lipid accumulation through regulation of ApoB secretion. |
| Q37590276 | Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance. |
| Q51590526 | Leucine restores murine hepatic triglyceride accumulation induced by a low-protein diet by suppressing autophagy and excessive endoplasmic reticulum stress. |
| Q33840334 | Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death |
| Q36682138 | Lipoprotein metabolism in nonalcoholic fatty liver disease |
| Q49843619 | Liver function and dysfunction - a unique window into the physiological reach of ER stress and the unfolded protein response |
| Q39233272 | Liver metabolic disruption induced after a single exposure to PCB126 in rats |
| Q42508123 | Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice |
| Q33457085 | Measurements of diacylglycerols in skeletal muscle by atmospheric pressure chemical ionization mass spectrometry |
| Q37145070 | Mechanism of the Inhibitory Effects of Eucommia ulmoides Oliv. Cortex Extracts (EUCE) in the CCl 4 -Induced Acute Liver Lipid Accumulation in Rats |
| Q36788344 | Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease |
| Q38981333 | Membrane Protein Quantity Control at the Endoplasmic Reticulum |
| Q35569304 | Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice |
| Q38245790 | MicroRNA regulation of mitochondrial and ER stress signaling pathways: implications for lipoprotein metabolism in metabolic syndrome |
| Q24629354 | MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism |
| Q36302709 | Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver |
| Q36579792 | Modulation of the unfolded protein response during hepatocyte and cardiomyocyte apoptosis in trauma/hemorrhagic shock |
| Q38260582 | Molecular insights into the mechanisms of liver-associated diseases in early-lactating dairy cows: hypothetical role of endoplasmic reticulum stress |
| Q89220189 | Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease |
| Q36470320 | Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease |
| Q51076739 | Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice. |
| Q33673712 | Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B |
| Q48379148 | Normalization of Hepatic Homeostasis in the Npc1nmf164 Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat |
| Q37670086 | Nuclear Receptors Resolve Endoplasmic Reticulum Stress to Improve Hepatic Insulin Resistance |
| Q92592890 | Nuclear envelope-localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis |
| Q61443337 | Nuclear lipid droplets derive from a lipoprotein precursor and regulate phosphatidylcholine synthesis |
| Q34024668 | Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance |
| Q33623354 | Nutrient sensing and inflammation in metabolic diseases |
| Q42578244 | Old and rising stars in the lymphoid liver |
| Q42079508 | Oleate inhibits steryl ester synthesis and causes liposensitivity in yeast. |
| Q83012613 | Oleic acid decreases the expression of a cholesterol transport-related protein (NPC1L1) by the induction of endoplasmic reticulum stress in CaCo-2 cells |
| Q41468088 | PKC{delta} is activated in a dietary model of steatohepatitis and regulates endoplasmic reticulum stress and cell death. |
| Q37096266 | Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it |
| Q58774678 | Pathophysiology of Diabetic Dyslipidemia |
| Q90284250 | Pirfenidone prevents and reverses hepatic insulin resistance and steatohepatitis by polarizing M2 macrophages |
| Q46457925 | Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice |
| Q36635369 | Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver |
| Q36324486 | Protective Effects of Alisma orientale Extract against Hepatic Steatosis via Inhibition of Endoplasmic Reticulum Stress |
| Q48172407 | Rab18 promotes lipid droplet (LD) growth by tethering the ER to LDs through SNARE and NRZ interactions |
| Q92923076 | Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma |
| Q33863614 | Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion |
| Q37802379 | Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities |
| Q33974369 | Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells |
| Q36114917 | Reducing endoplasmic reticulum stress does not improve steatohepatitis in mice fed a methionine- and choline-deficient diet |
| Q57066893 | Role of SREBPs in Liver Diseases: A Mini-review |
| Q41084455 | SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. |
| Q37463911 | SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease |
| Q41680966 | Silica nanoparticles induce endoplasmic reticulum stress response, oxidative stress and activate the mitogen-activated protein kinase (MAPK) signaling pathway |
| Q34615491 | Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans |
| Q42391560 | Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease |
| Q38132652 | Targeting the unfolded protein response in disease. |
| Q42970598 | Temporal clustering of gene expression links the metabolic transcription factor HNF4α to the ER stress-dependent gene regulatory network |
| Q39972673 | The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway |
| Q54945589 | The Effect of Amygdalin on Endoplasmic Reticulum (ER) Stress Induced Hepatic Steatosis in Mice. |
| Q60949658 | The Role of RNA Editing in Cancer Development and Metabolic Disorders |
| Q34860549 | The contribution of endoplasmic reticulum stress to liver diseases |
| Q26824858 | The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways |
| Q36954679 | The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease |
| Q37339542 | The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism |
| Q37264190 | The genetics of neutral lipid biosynthesis: an evolutionary perspective |
| Q36062081 | The impact of the unfolded protein response on human disease |
| Q37240302 | The many intersecting pathways underlying apolipoprotein B secretion and degradation |
| Q37867697 | The mechanistic basis for the induction of hepatic steatosis by xenobiotics |
| Q38162132 | The unfolded protein response in fatty liver disease |
| Q41904044 | The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis |
| Q38776013 | Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis |
| Q41136131 | Trans-10, cis 12-Conjugated Linoleic Acid-Induced Milk Fat Depression Is Associated with Inhibition of PPARγ Signaling and Inflammation in Murine Mammary Tissue |
| Q34338305 | Transcriptome sequencing and analysis of wild Amur Ide (Leuciscus waleckii) inhabiting an extreme alkaline-saline lake reveals insights into stress adaptation |
| Q37263956 | Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice |
| Q47719467 | Triglyceride Metabolism in the Liver. |
| Q42014494 | Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway |
| Q37606854 | Up-regulation of endoplasmic reticulum stress induced genes of the unfolded protein response in the liver of periparturient dairy cows |
| Q45753845 | Up-regulation of stearoyl-CoA desaturase 1 increases liver MUFA content in obese Zucker but not Goto-Kakizaki rats |
| Q55253186 | Vildagliptin Can Alleviate Endoplasmic Reticulum Stress in the Liver Induced by a High Fat Diet. |
| Q33904744 | α-Linolenic acid prevents endoplasmic reticulum stress-mediated apoptosis of stearic acid lipotoxicity on primary rat hepatocytes |
Search more.